TrialAnnals of surgical oncology2024

Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial.

Xiong Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.